We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Infectious Disease Diagnostics – Products

The Native Antigen Company Wins ‘The Best COVID-19 Responder’ at OBN 2020 Awards content piece image
Product News

The Native Antigen Company Wins ‘The Best COVID-19 Responder’ at OBN 2020 Awards

The Native Antigen Company, part of LGC Clinical Diagnostics and a supplier of reagents that enables research into diagnostics and vaccines for emerging and endemic infectious diseases, won ‘The Best COVID-19 Responder’ at OBN 2020 Awards.
MHRA Confirms Registration of Avacta’s AffiDX SARS-CoV-2 Antigen Lateral Flow Test content piece image
Product News

MHRA Confirms Registration of Avacta’s AffiDX SARS-CoV-2 Antigen Lateral Flow Test

Avacta Group plc is pleased to announce that the MHRA has confirmed registration of Avacta’s AffiDX® SARS-CoV-2 antigen lateral flow test allowing the Company to place the product on the market in the UK for professional use.
SP Delivers World’s Largest Installation of Freeze Dryers for Diagnostics  content piece image
Product News

SP Delivers World’s Largest Installation of Freeze Dryers for Diagnostics

Scientific Products has announced one of the world’s largest simultaneous installations of commercial lyophilizers for use in the production of diagnostic tests. The order, for SP lyophilizers, was made last year in response to the need for an increase in SARS-CoV-2 testing.
Oxford Immunotec’s T-SPOT Discovery SARS-CoV-2 Test Used in UK COVID-19 Human Challenge Study content piece image
Product News

Oxford Immunotec’s T-SPOT Discovery SARS-CoV-2 Test Used in UK COVID-19 Human Challenge Study

Oxford Immunotec has announced that its T-SPOT® Discovery SARS-CoV-2 kit is being used for T cell testing in the UK COVID-19 Human Challenge Study, a national collaboration including the UK government, the NHS, academia and the private sector.
UK Diagnostic Company Collaborates With UK COV-AD Trial content piece image
Product News

UK Diagnostic Company Collaborates With UK COV-AD Trial

Oxford Immunotec has announced that its T-SPOT®.COVID test will be used for T cell testing in the COV-AD (COVID infection in patients with Antibody Deficiency) study in collaboration with the University of Birmingham.
Bio-Rad Launches Its Reliance SARS-CoV-2 RT-PCR Assay Kit in Europe content piece image
Product News

Bio-Rad Launches Its Reliance SARS-CoV-2 RT-PCR Assay Kit in Europe

Bio-Rad Laboratories, Inc. has announced the launch of the Reliance SARS-CoV-2 RT-PCR Kit (IVD) for European markets after having met the CE-IVD mark requirements.
UK Diagnostic Company Collaborates With UK Com-COV Vaccine Trial content piece image
Product News

UK Diagnostic Company Collaborates With UK Com-COV Vaccine Trial

Oxford Immunotec has announced that its T-SPOT® Discovery SARS-CoV-2 kit will be used for T cell testing in the UK Com-COV trial.
Avacta Receives Clinical Validation of AffiDX SARS-CoV-2 Antigen Lateral Flow Test content piece image
Product News

Avacta Receives Clinical Validation of AffiDX SARS-CoV-2 Antigen Lateral Flow Test

Avacta Group plc has announced positive data from the clinical validation of its AffiDX® SARS-CoV-2 antigen lateral flow test.
AnteoTech Secures CE Certification for Its Versatile EuGeni Rapid Diagnostic Platform content piece image
Product News

AnteoTech Secures CE Certification for Its Versatile EuGeni Rapid Diagnostic Platform

AnteoTech has announced that its EuGeni™ Reader and accompanying COVID-19 Antigen Rapid Test (ART) have received Conformité Européene (CE) Mark registration as the company looks to progress with European distribution.
Mologic’s COVID-19 Rapid Antigen Self-Test Selected by NIH for RADx Initiative Funding content piece image
Product News

Mologic’s COVID-19 Rapid Antigen Self-Test Selected by NIH for RADx Initiative Funding

Mologic has announced that its rapid antigen self-test for COVID-19 has been selected by the Rapid Acceleration of Diagnostics initiative launched by the U.S. National Institutes of Health. The initiative aims to speed innovation in the development, commercialization, and implementation of technologies for COVID-19 testing.
Advertisement